Login
Toggle sidebar

Lint: ovarian-tumours

ovarian-tumours
Emphasis
warning

"BRCA1/BRCA2 mutations: particularly for serous types"

Line 8:8 · Italics should be used only in exceptional circumstances: '<em>BRCA1</em>'

"struma ovarii tumour"

Line 61:11 · Italics should be used only in exceptional circumstances: '<em>struma</em>'
List Caps
warning

"Brenner tumour: ~2.5% of ovarian epithelial neoplasms"

Line 43:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Krukenberg tumour"

Line 113:15 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Brenner tumour"

Line 127:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Acronyms
warning

"AFP levels: elevated particularly with immature ovarian teratomas and ovarian yolk sac tumours ref"

Line 138:11 · 'AFP' has no definition. Spell it out if it's unfamiliar to the audience.

"β HCG: elevated in dysgerminomas ref"

Line 139:13 · 'HCG' has no definition. Spell it out if it's unfamiliar to the audience.

"The FIGO staging system is used for almost all of ovarian cancers: see ovarian cancer staging."

Line 144:11 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Primary ovarian tumours"

Line 22:1 · "Primary ovarian tumours" is not a recognised heading for this article type.

"Mixed"

Line 96:1 · "Mixed" is not a recognised heading for this article type.

"Other"

Line 102:1 · "Other" is not a recognised heading for this article type.

"Classification according to morphology"

Line 116:1 · "Classification according to morphology" is not a recognised heading for this article type.

"Predominantly cystic"

Line 117:1 · "Predominantly cystic" is not a recognised heading for this article type.

"Predominantly solid"

Line 125:1 · "Predominantly solid" is not a recognised heading for this article type.

"Staging"

Line 143:1 · "Staging" is not a recognised heading for this article type.
Semicolons
suggestion

"ovarian serous cystadenocarcinoma: ~25% of serous tumours; commonest malignant ovarian tumour"

Line 30:72 · Use semicolons judiciously.

"CA-125 levels: elevated in most ovarian malignancies (~80% specificity); early-stage cancer often not elevated 17"

Line 137:86 · Use semicolons judiciously.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
7
8
0
0
0
0
0
0
0
0
0
0
0
0